Erica De Vita

Dr. Erica De Vita

Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Tuscany, Italy

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
GAGuglielmo Arzilli
Guglielmo Arzilli
EVErica De Vita
Erica De Vita
MPMilena Pasquale
Milena Pasquale
LCLuca Marcello Carloni
Luca Marcello Carloni
MPMarzia Pellegrini
Marzia Pellegrini
CRCaterina Rizzo
Caterina Rizzo
Healthcare-associated infections (HAIs) pose significant challenges in healthcare systems, with preventable surveillance playing a crucial role. Traditional surveillance, although effective, is resource-intensive. The development of new technologies, such as artificial intelligence (AI), can support traditional surveillance in analysing an increasing amount of health data or meeting patient needs. We conducted a scoping review, following the PRISMA-ScR guideline, searching for studies of new digital technologies applied to the surveillance, control, and prevention of HAIs in hospitals and LTCFs published from 2018 to 4 November 2023. The literature search yielded 1292 articles. After title/abstract screening and full-text screening, 43 articles were included. The mean study duration was 43.7 months. Surgical site infections (SSIs) were the most-investigated HAI and machine learning was the most-applied technology. Three main themes emerged from the thematic analysis: patient empowerment, workload reduction and cost reduction, and improved sensitivity and personalization. Comparative analysis between new technologies and traditional methods showed different population types, with machine learning methods examining larger populations for AI algorithm training. While digital tools show promise in HAI surveillance, especially for SSIs, challenges persist in resource distribution and interdisciplinary integration in healthcare settings, highlighting the need for ongoing development and implementation strategies.

6 July 2020 in BMJ
Verified
Journal Article
Closed access
PDF file
VCVirginia Casigliani
Virginia Casigliani
FNFrancesca De Nard
Francesca De Nard
EVErica De Vita
Erica De Vita
GAGuglielmo Arzilli
Guglielmo Arzilli
FGFrancesca Maria Grosso
Francesca Maria Grosso
PLPierluigi Lopalco
Pierluigi Lopalco

18 May 2020 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
RMR. Monali
R. Monali
EVErica De Vita
Erica De Vita
FMF. Mariottini
F. Mariottini
GPG. Privitera
G. Privitera
PLPier Luigi Lopalco
Pier Luigi Lopalco
LTL. Tavoschi
L. Tavoschi
Surveillance of new cases of invasive pneumococcal disease (IPD) in Italy was started in 2007 by the Ministry of Health (MoH). In 2012, pneumococcal childhood vaccination was introduced at the national level and, in 2017, for citizens aged 65 years and over. We describe here IPD epidemiology in Italy over the past 10 years investigating the impact of the vaccine programme on disease burden. Reports of IPD cases, data on serotype and vaccination coverage (VC) data were obtained from MoH annual reports, for the period 2007–2017. IPD notification rate and proportion by year, region, age and serotype were calculated. In 2007, 525 cases were reported (rate 0.88/100 000), rising to 1703 cases (rate 2.82/100 000) in 2017. The distribution of IPD cases by age group over time registered the largest share among individuals aged 65 years and over. A decreasing trend in notification rate was observed among those aged 0–4 years. During the same period, the 24-month VC increased, ranging from 80.9% to 96.7% in 2017. Molecular data indicated re-emergence of PPSV23-specific serotypes and non-vaccine serotypes. We observed an increase in IPD notifications during 2007–2017, likely due to an improved surveillance system, at least in some regions, with the relative quota of IPD notifications decreasing among vaccinated children cohorts. Further strengthening of IPD surveillance system, including molecular and vaccine coverage data, would be needed to assess and inform pneumococcal vaccination strategies in Italy.

1 March 2021 in Environmental Research
Verified
Journal Article
Closed access
ACA.L. Carducci
A.L. Carducci
AAA. Agodi
A. Agodi
CAC. Ancona
C. Ancona
PAP. Angelini
P. Angelini
FBF. Bagordo
F. Bagordo
MVM. Vassallo
M. Vassallo

27 July 2024 in Journal of Viral Hepatitis
Verified
Journal Article
Open access
MFMaria Paola Tramonti Fantozzi
Maria Paola Tramonti Fantozzi
LCLuca Ceccarelli
Luca Ceccarelli
DPDavide Petri
Davide Petri
EVErica De Vita
Erica De Vita
AAAntonello Agostini
Antonello Agostini
LTLara Tavoschi
Lara Tavoschi
HCV infection poses a global health threat, with significant morbidity and mortality. This study examines HCV trends in a large Italian region from 2015 to 2022, considering demographic changes, evolving clinical profiles, treatment regimens and outcomes, including the impact of the COVID‐19 pandemic. This multicentre retrospective study analysed demographics, clinical histories and risk factors in 6882 HCV patients. The study spanned before and after the direct‐acting antiviral (DAA) era, and the COVID‐19 period, focusing on treatment outcomes (SVR12, non‐SVR12 and patients lost to follow‐up). Statistical methods included ANOVA, multinomial logistic regression, Kruskal–Wallis test and chi‐square analysis, and were conducted adhering to the intention‐to‐treat (ITT) principle. The cohort, mainly Italian males (average age 58.88), showed Genotype 1 dominance (56.6%) and a high SVR12 rate (97.5%). The pandemic increased follow‐up losses, yet SVR12 rates remained stable, influenced by factors like age, gender, cirrhosis and comorbidities. Despite COVID‐19 challenges, the region sustained high SVR12 rates in HCV care, emphasising the importance of sustained efforts in HCV care. Continuous screening and targeted interventions in high‐risk populations are crucial for achieving WHO elimination targets. The study highlights the resilience of HCV care during the pandemic and provides insights for future public health strategies.

8 April 2020 in European Journal of Public Health
Verified
Journal Article
Open access
PDF file
IPIrene Psaroudakis
Irene Psaroudakis
FQFilippo Quattrone
Filippo Quattrone
LTLara Tavoschi
Lara Tavoschi
EVErica De Vita
Erica De Vita
SCSilvia Cervia
Silvia Cervia
PLPietro Luigi Lopalco
Pietro Luigi Lopalco
Adolescents engagement is fundamental to develop dedicated educational interventions. We piloted non-standard sociological methodology to assess risk perception, information sources and perceived educational needs of a group of Italian adolescents focusing on three infectious diseases. Three high-school classes students participated in a World Café event. A thematic analysis was performed. Participants showed lack of knowledge on diseases prevention. Family and school were key health information sources and social media considered unreliable. Future interventions preferences included interactive and informal sessions. We showed the utility of non-standard sociological methods to assess health knowledge among adolescents and enhance the design of dedicated interventions.